Pharmafile Logo
Pharmafocus logo
Advanced Search

Generics firm press for ‘clear and open’ market

February 8, 2010
Sales and Marketing generics, industry

Generic drug companies have set out their vision of a more ‘clear’ and ‘open’ market in Europe. Greg Perry, director …

News

Carbogen Amcis opens large-scale high-potency API plant

February 8, 2010
Manufacturing and Production Carbogen Amcis, Dishman, India

Carbogen Amcis, the Swiss subsidiary of Dishman Pharmaceuticals and Chemicals of India, has opened a new high-potency active pharmaceutical ingredient …

News

GSK appoints Philippe Fauchet president of GSK Japan

February 8, 2010
Sales and Marketing GlaxoSmithKline, appointment, sales and marketing

GSK has appointed Philippe Fauchet president of GSK Japan, reporting to to Marc Dunoyer who takes a new role as …

Appointment

Pharma manufacturing news in brief

February 8, 2010
Manufacturing and Production, Medical Communications Angel Biotech, Catalent, Enzon, Genzyme, Gorbec Pharmaceuticals Services, Peakdale Molecular, Pfizer, Sigma-Tau, Synco Bio Partners

Our round-up of news in the pharmaceutical manufacturing arena covers developments at Genzyme, Enzon/Sigma-Tau, Catalent, Synco Bio Partners, Angel Biotech, …

News
UK swine flu leaflet

UK swine flu cases fall

February 5, 2010
Sales and Marketing h1n1, swine flu

The government has warned against complacency over swine flu as it released figures showing UK cases had fallen to one …

News

GSK looks to rare diseases research

February 5, 2010
Research and Development GlaxoSmithKline, Orphan

GlaxoSmithKline has launched a new specialist unit to research and develop medicines for rare diseases. The company has identified 5,500 …

News
Cohn and Wolfe Mike Kan

Cohn & Wolfe appoints Mike Kan

February 5, 2010
Medical Communications Cohn & Wolfe, appointment, medical communications

Cohn & Wolfe has appointed Mike Kan as global healthcare practice leader. He assumes the role from Linda Dyson who …

Appointment

Recipharm charms Cobra shareholders into selling up

February 5, 2010
Manufacturing and Production Cobra, Recipharm, Wasserburger

Swedish contract development and manufacturing organisation (CDMO) Recipharm has said that its takeover bid for UK company Cobra Biomanufacturing has …

News
ABPI

Barker praises OLS model

February 5, 2010
Research and Development, Sales and Marketing ABPI, Blueprint, OLS

The ABPI’s director general spoke to Pharmafocus about the promise of the new Blueprint at its launch in London last …

News
Andrew Witty

GSK confirms job cuts but avoids specifics

February 5, 2010
Research and Development, Sales and Marketing 2009 financials, GlaxoSmithKline

GlaxoSmithKline has sidestepped questions about the internal fall-out from its new plan to slash R&D infrastructure costs. Presenting the company’s …

News
Photo_Miguel_Forte300dpi

Miguel Forte joins TxCell

February 5, 2010
Research and Development TxCell, appointment, research and development

French biotech TxCell has appointed Miguel Forte to fill its newly-created role of chief medical officer. Miguel joins the company …

Appointment

Portfolio Harmony in five easy steps

February 5, 2010
Sales and Marketing product portfolio

Portfolio planning should be a practical process that delivers a programme of work to take you to sunnier shores. All …

Feature

Zeftera problems weigh down Basilea

February 5, 2010
Sales and Marketing 2009 financials, Basilea, Zeftera

Specialist Swiss pharma company Basilea has announced a doubling of its revenues in 2009, thanks to the launch of its …

News

GSK acquires respiratory candidate

February 4, 2010
Research and Development Apeiron, GlaxoSmithKline, respiratory

GlaxoSmithKline has acquired exclusive rights to a biotherapeutic enzyme developed for use against Acute Respiratory Distress Syndrome (ARDS). The move …

News
Pfizer World

Wyeth acquisition yet to shake Pfizer’s Lipitor dependence

February 4, 2010
Sales and Marketing 2009 financials, Lipitor, Pfizer

Pfizer’s profits rose by 7% last year on the back of a 4% increase in revenue driven by cholesterol treatment …

News

Fishawack makes US acquisition

February 4, 2010
Medical Communications Nexus Communications, fishawack

Cheshire-based healthcare agency Fishawack Communications has bought US outfit Nexus Communications. The company says this acquisition is part of a …

News

Oxford Immunotec appoints Frank Vandeputte

February 4, 2010
Sales and Marketing Oxford Immunotec, appointment, medical devices, sales and marketing

Medical diagnostics company Oxford Immunotec has appointed Frank Vandeputte vice president, sales and marketing. He was formerly VP, Europe for …

Appointment

Eden Biodesign passes into Watson Pharma’s hands

February 4, 2010
Manufacturing and Production Eden Biodesign, Watson Pharma, biologicals

UK biologics manufacturing specialist Eden Biodesign has been bought by US drugmaker Watson Pharmaceuticals in a $15 million deal. The …

News

Lancet retracts MMR research conclusions

February 3, 2010
Research and Development MMR, Sanofi, vaccines

The Lancet, the journal which originally published the controversial research linking the MMR vaccine to autism has issued a full …

News

Digital Pharma: New EMA website previewed

February 3, 2010
Research and Development, Sales and Marketing EMA, branding, digital pharma

The European Medicines Agency is preparing to overhaul its website to make it easier for users to get information. This …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026